دورية أكاديمية
أعرض في EDS

Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice.

التفاصيل البيبلوغرافية
العنوان: Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice.
المؤلفون: van den Bosch CH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. C.H.vandenBosch-4@prinsesmaximacentrum.nl., Spijkerman J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hovinga ICLK; Van Creveldkliniek University Medical Centre Utrecht, Thrombosis and Hemostasis, Benign Hematology, Utrecht, The Netherlands., Meyer-Wentrup FAG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van de Wetering MD; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Mathematical Institute, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Morsing IE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Oct; Vol. 30 (10), pp. 8069-8079. Date of Electronic Publication: 2022 Jul 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer International, c1993-
مواضيع طبية MeSH: Catheter-Related Infections*/epidemiology , Catheter-Related Infections*/etiology , Catheter-Related Infections*/prevention & control , Catheterization, Central Venous*/adverse effects , Catheterization, Peripheral*/adverse effects , Central Venous Catheters*/adverse effects , Hodgkin Disease*/complications , Hodgkin Disease*/drug therapy , Thrombosis*/etiology , Venous Thrombosis*/epidemiology , Venous Thrombosis*/etiology, Anticoagulants ; Child ; Humans ; Retrospective Studies ; Risk Factors
مستخلص: Purpose: The purpose of this study was to determine the most optimal central venous catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications.
Methods: A retrospective study including patients diagnosed with HL from 2015 to 2021 at the Princess Máxima Center was performed. Patients were followed from CVC insertion until removal or 06-2021, whichever came first. The primary outcome was the CVC-related complication incidence rate (IR) per 1000 CVC-days. Furthermore, the incidence rate ratio (IRR) was calculated by comparing complication IRs between peripherally inserted central catheters (PICC) and totally implantable venous access ports (TIVAP). Additionally, risk factors for central venous thrombosis (CVT) were identified.
Results: A total of 98 patients were included. The most frequently observed complications were local irritation/infections (18%; IR 0.93), malfunctions (15%; IR 0.88), and CVC-related CVTs (10%; IR 0.52). Single lumen PICCs were associated with a higher risk of complications (49% vs. 26%; IRR 5.12, CI95% 2.76-9.50), severe complications (19% vs. 7%; IRR 11.96, CI95% 2.68-53.42), and early removal (18% vs. 7%; IRR 9.96, CI95% 2.18-45.47). A single lumen PICC was identified as a risk factor for CVC-related CVT when compared to TIVAPs (12% vs. 7%, IRR 6.98, CI95% 1.45-33.57).
Conclusion: The insertion of a TIVAP rather than a PICC should be recommended for pediatric patients with HL, especially in the presence of CVT-related risk factors. Future trials should evaluate the efficacy and safety of direct oral anticoagulants for the primary prevention of CVT in pediatric patients with a PICC and other CVT-related risk factors.
(© 2022. The Author(s).)
References: Lancet. 2021 Jul 31;398(10298):367-368. (PMID: 34297999)
Cancer Nurs. 2020 Nov/Dec;43(6):455-467. (PMID: 31464692)
Epidemiology. 1996 Jan;7(1):29-33. (PMID: 8664397)
Blood. 2020 Jan 16;135(3):220-226. (PMID: 31909784)
Pediatrics. 2015 Nov;136(5):e1331-44. (PMID: 26459655)
Thromb Res. 2018 Apr;164:129-135. (PMID: 28811041)
Ann Surg. 2004 Aug;240(2):205-13. (PMID: 15273542)
Intern Med J. 2020 Dec;50(12):1475-1482. (PMID: 32043739)
Pediatr Blood Cancer. 2020 Feb;67(2):e28057. (PMID: 31736198)
Clin Infect Dis. 2011 May;52(9):e162-93. (PMID: 21460264)
Cancer Treat Rep. 1977 Sep;61(6):1023-7. (PMID: 902260)
Cancers (Basel). 2020 May 20;12(5):. (PMID: 32443753)
Medicine (Baltimore). 2019 Nov;98(47):e17894. (PMID: 31764785)
Front Pediatr. 2017 Feb 06;5:12. (PMID: 28220143)
Am J Cardiovasc Drugs. 2019 Dec;19(6):525-539. (PMID: 30941708)
Pediatr Blood Cancer. 2021 May;68(5):e28957. (PMID: 33624938)
Epidemiology. 1991 Sep;2(5):359-62. (PMID: 1742385)
Lancet. 2013 Jul 27;382(9889):311-25. (PMID: 23697825)
Clin J Oncol Nurs. 2020 Feb 1;24(1):58-64. (PMID: 31961846)
Lancet Haematol. 2021 Jan;8(1):e22-e33. (PMID: 33290737)
Lancet Haematol. 2020 Jan;7(1):e18-e27. (PMID: 31699660)
Blood Adv. 2021 Feb 23;5(4):927-974. (PMID: 33570602)
Acta Anaesthesiol Scand. 2020 Mar;64(3):385-393. (PMID: 31721153)
BMJ. 2000 May 6;320(7244):1240-3. (PMID: 10797032)
J Clin Oncol. 2014 Sep 20;32(27):3059-68. (PMID: 25113753)
Thromb Res. 2017 Apr;152:64-68. (PMID: 28249199)
Br J Anaesth. 2019 Jun;122(6):734-741. (PMID: 31005243)
Ann Oncol. 2019 Aug 1;30(8):1192-1193. (PMID: 31132097)
Thromb Res. 2008;122(4):459-65. (PMID: 18237767)
Pediatr Blood Cancer. 2016 Aug;63(8):1438-44. (PMID: 27128820)
Lancet. 2021 Jul 31;398(10298):403-415. (PMID: 34297997)
J Pediatr Surg. 2019 Sep;54(9):1894-1900. (PMID: 30415957)
Blood. 2020 Feb 13;135(7):491-504. (PMID: 31805182)
BMJ Open. 2021 Jul 5;11(7):e045895. (PMID: 34226216)
Hamostaseologie. 2020 Feb;40(1):64-73. (PMID: 32050291)
Ann Oncol. 2019 Aug 1;30(8):1329-1334. (PMID: 31132094)
Clin Infect Dis. 2009 Jul 1;49(1):1-45. (PMID: 19489710)
فهرسة مساهمة: Keywords: Central venous catheter; Complications; Hodgkin lymphoma; Pediatric; Thrombosis
المشرفين على المادة: 0 (Anticoagulants)
تواريخ الأحداث: Date Created: 20220701 Date Completed: 20220928 Latest Revision: 20220929
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9512752
DOI: 10.1007/s00520-022-07256-3
PMID: 35776186
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-7339
DOI:10.1007/s00520-022-07256-3